

£ 94.99
REJURAN® I – 1ml
REJURAN® I is a specialised c-PDRN skin rejuvenation treatment developed specifically for the delicate skin surrounding the eyes. Formulated with Concentrated Polydeoxyribonucleotide (c-PDRN), REJURAN® I is designed to support cellular regeneration, collagen production, skin repair, elasticity and hydration, helping to improve the overall quality and appearance of the periorbital skin.
Unlike traditional dermal fillers that are primarily designed to restore or create volume, REJURAN® I focuses on improving skin quality through regenerative support. Its highly purified c-PDRN formulation is designed to encourage the skin's natural regenerative processes, supporting fibroblast activity and collagen production while helping to improve dermal strength, texture and resilience over time.
Its lower-viscosity formulation has been specifically developed for use within delicate facial tissues, making REJURAN® I particularly suited to professional periorbital rejuvenation protocols where improvements in hydration, elasticity, fine lines, crepey skin and overall skin quality are desired without unnecessary volumisation.
Pack Contents
Each pack contains:
• 1 × 1ml pre-filled syringe of REJURAN® I
• Sterile needles, as supplied by the manufacturer
• Sterile professional-use packaging
Each syringe is supplied in sterile, sealed packaging to help maintain product integrity and ensure suitability for professional clinical use.
Always check the individual product packaging and manufacturer's current Instructions for Use before treatment.
Product Composition
Hydrolysed DNA (c-PDRN) – 10mg/ml
REJURAN® I contains Hydrolysed DNA (c-PDRN) at a concentration of 10mg/ml.
The highly purified Polydeoxyribonucleotide is produced using REJURAN's proprietary DNA Optimising Technology (DOT™). These purified DNA fragments are designed to support cellular regeneration, fibroblast activity, collagen production, dermal repair and improvements in overall skin quality.
Rather than providing structural facial volume, the formulation is focused on supporting the biological condition, hydration, elasticity and resilience of the skin.
Physiological Buffer Solution
The formulation also contains a physiological buffer solution designed to maintain product stability and support appropriate administration.
REJURAN® DOT™ Technology
REJURAN® I utilises proprietary DNA Optimising Technology (DOT™) to produce highly purified Hydrolysed DNA (c-PDRN) derived from carefully purified wild salmon DNA.
The DNA fragments are selected for their biocompatibility and are designed to support the skin's natural regenerative processes, encouraging fibroblast activity, collagen production and healthier dermal architecture.
Its lower-viscosity formulation makes REJURAN® I particularly suited to delicate treatment areas where improvements in skin quality are desired without creating unnecessary volume.
Periorbital Skin Rejuvenation
REJURAN® I has been specifically developed for the delicate periorbital region, where the skin is naturally thinner and may show visible signs of ageing, dehydration and reduced elasticity.
The treatment is designed to support progressive improvements in skin quality rather than provide the structural correction associated with traditional dermal fillers.
Professional treatment protocols may therefore focus on concerns including:
• Fine lines around the eyes
• Crepey-looking under-eye skin
• Reduced skin elasticity
• Dehydrated-looking skin
• Poor skin texture
• Reduced skin firmness
• Overall deterioration in periorbital skin quality
Where dark circles are present, practitioners should consider their underlying cause as pigmentation, vascular visibility, anatomical shadowing, volume loss and skin quality can all contribute to the appearance of under-eye darkness and may require different treatment approaches.
Key Benefits
• Advanced regenerative periorbital treatment
• Developed specifically for the delicate eye area
• Contains Hydrolysed DNA (c-PDRN)
• Contains 10mg/ml c-PDRN
• Manufactured using proprietary DOT™ Technology
• Supports natural cellular regeneration
• Supports fibroblast activity and collagen production
• Helps improve skin elasticity
• Supports healthier dermal structure
• Promotes improved skin hydration
• Helps improve skin firmness
• Helps soften the appearance of fine lines
• Helps improve crepey-looking skin around the eyes
• Supports smoother-looking skin texture
• Helps improve overall skin quality and resilience
• Designed for progressive skin rejuvenation rather than facial volumisation
• Suitable for professional periorbital rejuvenation protocols
• Supplied as a 1ml pre-filled syringe
• Intended strictly for appropriately qualified professional use
Common Treatment Areas
REJURAN® I is specifically developed for the delicate periorbital region.
Professional treatment areas may include:
• Under-eye area
• Lower eyelid region
• Crow's feet
• Periorbital region
• Fine lines surrounding the eyes
Treatment suitability should always be determined according to the patient's individual anatomy, skin quality, medical history, presenting concerns and professional assessment.
Practitioners should always follow the manufacturer's current recommendations regarding treatment technique, depth, dosage and product placement.
Recommended Treatment Protocol
A course of approximately 3–4 treatment sessions is commonly recommended, depending on individual patient requirements and practitioner assessment.
Initial Course: 3–4 treatments
Treatment Interval: Approximately every 2–4 weeks
Maintenance: Approximately every 6 months or according to individual patient requirements and professional assessment
Treatment protocols should always be tailored to the patient's skin condition, medical history, anatomy, treatment objectives and clinical assessment while following the manufacturer's current Instructions for Use.
Results & Longevity
Results from REJURAN® I develop progressively as the skin responds to the regenerative treatment process.
Potential improvements may include smoother and more hydrated-looking skin, improved elasticity, softening of fine lines, improved texture and an overall improvement in the quality and appearance of the periorbital skin.
Unlike a volumising dermal filler, the objective is progressive improvement in skin quality rather than immediate structural augmentation.
Following completion of an initial treatment programme, maintenance treatments may be recommended to help preserve improvements in skin quality and ongoing regenerative support.
Individual results and longevity will vary depending on factors including age, skin condition, lifestyle, treatment frequency, practitioner technique and individual biological response.
Important Information
REJURAN® I is intended strictly for use by appropriately qualified and trained medical or aesthetic professionals.
Professional knowledge of facial anatomy, particularly the delicate periorbital region, together with appropriate aseptic technique and safe administration protocols, is essential for appropriate product placement and patient safety.
Treatment should only be performed following a full patient consultation, medical assessment and informed consent in accordance with applicable professional standards, local regulations and the manufacturer's current Instructions for Use.
Suitability should be carefully assessed where contraindications or precautions may apply, including active infection or inflammation at the treatment site, known hypersensitivity to product components, pregnancy or breastfeeding, uncontrolled medical conditions or other factors identified during professional assessment.
Temporary treatment-related effects may include redness, swelling, bruising, tenderness, transient papules or localised discomfort at the treatment site.
Store and handle REJURAN® I according to the manufacturer's current recommendations and do not use after the stated expiry date or where product or packaging integrity is compromised.
For professional use only.
Compare insurance quotes from trusted partners.
32 products
99 sold